By Ernie Mundell HealthDay ReporterTHURSDAY, July 31, 2025 (HealthDay News) — There’s potentially exciting news from a trial ...

Plasma samples showed an association between suppressed extracellular vesicles and an increased risk for liver cancer.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...